We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+43.04%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.31B
AUM Growth
+$247M
Cap. Flow
-$43.7M
Cap. Flow %
-3.34%
Top 10 Hldgs %
57.19%
Holding
47
New
6
Increased
14
Reduced
13
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 99.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPCE icon
26
Neuropace
NPCE
$505M
$20.8M 1.59%
1,349,482
-10,589
-0.8% -$142K
MDXG icon
27
MiMedx Group
MDXG
$626M
$20.6M 1.57%
3,039,341
-613,611
-17% -$4.3M
ORGO icon
28
Organogenesis Holdings
ORGO
$308M
$20M 1.53%
3,862,820
-3,635,091
-48% -$17.6M
SEPN
29
Septerna Inc
SEPN
$1.49B
$17.3M 1.32%
+620,811
New +$14.8M
ABVX
30
Abivax
ABVX
$11B
$12M 0.91%
88,674
-7,281
-8% -$794K
BFLY icon
31
Butterfly Network
BFLY
$1.72B
$10.7M 0.82%
2,812,131
+1,684,133
+149% +$4.58M
DYN icon
32
Dyne Therapeutics
DYN
$4.04B
$3.04M 0.23%
+155,231
New +$2.94M
IWO icon
33
iShares Russell 2000 Growth ETF
IWO
$14.5B
$245K 0.02%
+760
New +$247K
ADMA icon
34
ADMA Biologics
ADMA
$1.92B
-1,069,233
Closed -$15.7M
ALHC icon
35
Alignment Healthcare
ALHC
$4.02B
-203,138
Closed -$3.54M
CDTX
36
DELISTED
Cidara Therapeutics
CDTX
-292,657
Closed -$28M
EVH icon
37
Evolent Health
EVH
$475M
-545,282
Closed -$4.61M
GPCR icon
38
Structure Therapeutics
GPCR
$3.49B
-197,350
Closed -$5.53M
MRUS
39
DELISTED
Merus
MRUS
-224,080
Closed -$21.1M
RARE icon
40
Ultragenyx Pharmaceutical
RARE
$2.65B
-285,699
Closed -$8.59M
RDNT icon
41
RadNet
RDNT
$4.84B
-42,280
Closed -$3.22M
RGEN icon
42
Repligen
RGEN
$7.44B
-41,427
Closed -$5.54M
SENS icon
43
Senseonics Holdings Inc
SENS
$254M
-900,382
Closed -$7.85M
LENZ
44
LENZ Therapeutics
LENZ
$172M
-693,044
Closed -$32.3M
TECX
45
Tectonic Therapeutic
TECX
$573M
-202,393
Closed -$3.18M
PHLT
46
DELISTED
Performant Healthcare Inc
PHLT
-11,718,612
Closed -$90.6M
CAI
47
Caris Life Sciences
CAI
$4.39B
-403,924
Closed -$11.9M

Similar funds

First Light Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, First Light Asset Management held 47 positions worth $1.31B, up 23% from $1.06B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

First Light Asset Management withdrew a net $43.7M in Q4 2025, closing 14 positions and reducing 13 holdings. Its most notable exit was Performant Healthcare Inc, an estimated $90.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, down from 100% a quarter earlier.

Against the trend, First Light Asset Management opened a new position in Tandem Diabetes Care worth $23.9M.

  • First Light Asset Management's largest Q4 2025 buy was Tandem Diabetes Care: 1,089,493 shares worth $23.9M.
  • First Light Asset Management added most to SI-BONE Inc in Q4 2025, an estimated $54.1M increase.
  • First Light Asset Management's biggest Q4 2025 reduction was Centessa Pharmaceuticals, cutting an estimated $34.4M.
  • First Light Asset Management fully exited Performant Healthcare Inc in Q4 2025, selling an estimated $90.6M.
  • First Light Asset Management's ten largest holdings make up 57% of its $1.31B portfolio in Q4 2025.
  • First Light Asset Management opened 6 new positions and closed 14 in Q4 2025.
  • First Light Asset Management's portfolio value rose 23% quarter-over-quarter to $1.31B.

Based on First Light Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.